MyFinsight
Home
Blog
About
Back
Income Statement
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)
source: myfinsight.com
Net loss
-$20,319,272
(-0.83%↓ Y/Y)
Net loss before
income taxes
-$20,319,272
(-0.83%↓ Y/Y)
Interest (income)
expense, net
$7
(100.01%↑ Y/Y)
Loss from operations
-$10,810,209
(31.36%↑ Y/Y)
(gain) loss from change
in fair value of...
$7,036,009
(251.87%↑ Y/Y)
(gain) loss on
extinguishment of debt
-$1,329,048
Gain from change in
fair value of...
$1,103,000
(-52.54%↓ Y/Y)
Loss (gain) on equity
method investment
-$41,013
(-32.80%↓ Y/Y)
cost of goods and
services sold
$16,965
Selling, general and
administrative
$7,550,845
(-21.99%↓ Y/Y)
Research and development
$3,251,099
(-54.43%↓ Y/Y)
Gross profit
-$8,265
(-100.78%↓ Y/Y)
Revenues, net
$8,700
(-99.42%↓ Y/Y)
gross profit
-$8,265
Cost of revenues
$16,965
(-96.14%↓ Y/Y)
Back